Compounded tirzepatide

VyrarX

VyrarX advertises $329 a month for compounded tirzepatide. We have not been able to confirm what the card is actually charged. That is the starting dose, and it rises as your dose does.

Advertised monthly$329
EvidenceReported
Billing cyclenot confirmed
Price across dosesClimbs with the dose
Where it shipsClaims every state
FDA warning letterNone found

Visit VyrarX

What it bills, and what that is per month

The $329 above is the seller's own monthly figure. It does not say how often the card is actually charged, so we cannot restate it over a calendar month or check it against a checkout. When that changes, the arithmetic appears here.

The price above is the starting dose, and it rises as your dose does. This seller does not publish how far, so treat it as an entry price rather than what you will be paying in six months.

Where it says it operates

VyrarX physicians are licensed across 47 states and provide safe, high-quality, evidence-based care. We do not serve California, South Carolina, or New Jersey.

Read on its own site in September 2026. It excludes California, South Carolina, New Jersey. This is the seller’s claim about the whole country, not a list of states we checked one by one.

What else this seller sells

The same seller appears in our data for one other medication.

Worked out the same way as the tirzepatide price above, and kept separate from it. How the two molecules compare at every seller that sells both: compounded tirzepatide vs compounded semaglutide.